UAB investigators have found a new pathway that contributes to an often fatal lung disease with no cure and no effective treatments, and possibly a way to shut that pathway down.
UAB treated the first patient in the nation in an experimental lung reduction procedure for emphysema.
The latest edition of Best Doctors in America ® recognizes 325 UAB physicians — voted by their peers as the best.
CT scans can help physicians predict which COPD patients are likely to take a turn for the worse, say UAB researchers.
A new drug that improves lung function for some patients with cystic fibrosis may also help treat smokers with the incurable lung disease COPD.
The Program in Environmental and Translational Medicine combines clinical care with research to prevent, treat diseases caused from air pollution, water contamination, other causes.
UAB doctors can now employ a new procedure, using thermal energy, to open constricted airways in patients whose severe asthma is not controlled by medication.
UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.
A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.
UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.